[Safety and efficacy of gefitinib for treatment of advanced non-small cell lung cancer]. [electronic resource]
Producer: 20080414Description: 66-9 p. digitalISSN:- 0253-3766
- Adenocarcinoma -- drug therapy
- Aged
- Antineoplastic Agents -- adverse effects
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Carcinoma, Squamous Cell -- drug therapy
- Diarrhea -- chemically induced
- Disease Progression
- Exanthema -- chemically induced
- Female
- Gefitinib
- Humans
- Kaplan-Meier Estimate
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Neoplasm Staging
- Quinazolines -- adverse effects
- Remission Induction
- Sex Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.